One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are diagnosed have a BRCA1 and BRCA2 (BReast CAncer) genetic mutation. These mutations naturally occur in biological family units, and women with these mutations live with an increased rate of breast/ovarian cancers. The standard of genetic counseling care is individualized counseling, in which one at-risk family member is tested at a time. A new and potentially more relevant genetic counseling approach, family-based genetic counseling, tests all at-risk family members at one time as one cohesive patient group. The current study explored lived experiences and preferences (i.e., individualized, family-based) of women who have tested positive for ...
Carriers of breast cancer gene (BRCA) mutations are asked to communicate genetic test results to the...
We offer a pilot model of genetic counseling patient care. Breast cancer (BC) patients when diagnose...
It remains uncertain whether members of hereditary breast and ovarian cancer (HBOC) families experie...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Due to the complexity of information surrounding BRCA1 / 2 counseling and testing and its time con...
Objective Female breast cancer patients carrying a BRCA1/2-mutation have an increased risk of second...
Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not bee...
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.This multicenter study evaluated ...
AbstractObjectiveFemale breast cancer patients carrying a BRCA1/2-mutation have an increased risk of...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
This qualitative study asked Australian Genetic Counselors and Clinical Geneticists working in cance...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
Carriers of breast cancer gene (BRCA) mutations are asked to communicate genetic test results to the...
We offer a pilot model of genetic counseling patient care. Breast cancer (BC) patients when diagnose...
It remains uncertain whether members of hereditary breast and ovarian cancer (HBOC) families experie...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
One in 8 women will be diagnosed with breast cancer in her lifetime, but only 5-10% of women who are...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Due to the complexity of information surrounding BRCA1 / 2 counseling and testing and its time con...
Objective Female breast cancer patients carrying a BRCA1/2-mutation have an increased risk of second...
Outcomes after genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome have not bee...
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.This multicenter study evaluated ...
AbstractObjectiveFemale breast cancer patients carrying a BRCA1/2-mutation have an increased risk of...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
This qualitative study asked Australian Genetic Counselors and Clinical Geneticists working in cance...
Genetic testing for a hereditary breast cancer predisposition has been available since 1996. Since t...
Carriers of breast cancer gene (BRCA) mutations are asked to communicate genetic test results to the...
We offer a pilot model of genetic counseling patient care. Breast cancer (BC) patients when diagnose...
It remains uncertain whether members of hereditary breast and ovarian cancer (HBOC) families experie...